Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis

NCT04955951 is registered in ClinicalTrials.gov with Ahram Canadian University as lead sponsor.

NCT NCT04955951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04955951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultrasonographic Response to Polarized Light Therapy in the Treatment of Atopic Dermatitis
Lead sponsor
Ahram Canadian University
Phase
Observational
Overall status
Terminated
Start date
July 1, 2021
Completion date
January 15, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic atopic dermatitis